ABOUT US
 

Shareholder Information

Exchange:    NASDAQ
Stock Ticker: BJCT
Transfer Agent/Stockholder Inquiries:
   American Stock Transfer & Trust Company
   (800) 397-5449 or (212) 936-5100
   59 Maiden Lane, New York, New York 10038
   http://www.amstock.com


Company Overview
Bioject Medical Technologies Inc. is an emerging drug delivery company developing the world's leading technology for needle-free injection of liquid medications. More >>

Real Time Stock Quote

 

 

 

 
FEATURED REPORTS SEC FILINGS FUNDAMENTALS
 2007 Annual Report All Filings Financials
 2008 Proxy Insider (Section 16) Key Stats & Ratios
 2006 Annual Report    
 2007 Proxy    

LATEST NEWS                           

01/23/08 Bioject Note Holders Convert at Premium with Series F Convertible Preferred Stock  
01/03/08 Bioject President and CEO to Present at OneMedPlace Emerging Healthcare Technologies Finance Forum  
12/06/07 Bioject at the Forefront of Product Development with Use of Biojector® 2000  
12/05/07 Bioject Secures Additional Funding to Reach Total of $1.2M Raised  
11/20/07 Bioject Announces Convertible Debt Financing  
11/05/07 Bioject President and CEO to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference  

AUDIO ARCHIVES  

03/18/08 Fourth Quarter 2007 and Year End Earnings Release (Replay) 03/18/07 at 7:00 a.m. PT
11/01/07 Third Quarter 2007 Earnings Release (Replay) 11/01/07 at 7:00 a.m. PT
06/11/07 Bioject Medical Technologies Inc. Annual Shareholders' Meeting
 

 

  

In order to view some of the documents on this page you need to have the free Adobe®Reader® software installed.